Brief: Amniotics Granted EU Patent For Stem Cell Technology Platform

Amniotics AB (publ)

08/06/2023 09:18

June 8 (Reuters) - Amniotics AB  AMNI.ST :
    * SAID ON WEDNESDAY EUROPEAN PATENT OFFICE HAS APPROVED
PATENT
APPLICATION FOR CO’S STEM CELL TECHNOLOGY PLATFORM
    * PATENT PROVIDES AMNIOTICS WITH EXCLUSIVE COMMERCIAL RIGHTS
IN
THE EU AT LEAST UNTIL 2040
    * PATENT INCLUDES PRODUCT CANDIDATE PULMOSTEM (LUNG), BUT IS
ALSO
HIGHLY RELEVANT TO THE OTHER CANDIDATES, E.G. COGNISTEM (BRAIN)

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nMFN4Qxw9C
 Further company coverage:  AMNI.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))